The current approach to study development presents an opportunity for meaningful change. By rethinking how we design, validate, and deploy trials, we can move beyond incremental improvements and begin addressing the fundamental challenges that have slowed down trial progress for years.
The life science space still relies on manual processes, fragmented systems, and outdated assumptions. By rethinking entrenched processes and assumptions, we aim to mitigate the bottlenecks, lower costs and better align system capabilities with user needs.
In this session, the General Manager of Zelta EDC/CDMS, Jennifer Duff and the Vice-President of Clinical Services, Judi Hall of Alimentiv will explore a vision for the future of clinical trial execution and its potential impact on the industry. We will examine how new system and database models could be built, validated, and launched in 24 hours – setting the stage for an entire new industry norm.
Key themes include:
- Implementing holistic study development using protocol-aware automation
- AI assisted management of standards and impact assessments
- Providing tools for easier adoption of risk-based testing
- Breaking down the siloed system mentality plaguing the industry
We will highlight how instant builds are not just about speed, but also trust, traceability, and transformation at scale. Attendees will gain insight into how innovative thinking and emerging practices are reshaping expectations through Zelta’s radical innovation and what it could mean for the future of data management.
Register now!
Back
